Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Oxycontin (oxycodone er) Treatment Report
What is Oxycontin?

Oxycontin is a brand name for the extended release preparation of the drug oxycodone, a narcotic analgesic drug used to treat or prevent moderate to severe pain. Oxycontin is a brand name owned by Purdue Pharmaceuticals. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Pain 13 0
Nerve pain (neuropathic pain) 1 0

Mouse over the table for more information

Dosages

  10mg as needed 10 mg daily 20 mg daily 60 mg daily 100 mg daily 120 mg daily 240 mg daily 250 mg daily
  1 Number of Patients: 1 4 Number of Patients: 4 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Oxycontin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
2 50% Side effects too severe: 50%
Did not seem to work
1 25% Did not seem to work: 25%
Expense
1 25% Expense: 25%
Doctor's advice
1 25% Doctor's advice: 25%

See all 4 patients who’ve stopped taking Oxycontin

Currently Taking Oxycontin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
1
1
0

Stopped Taking Oxycontin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
2
1
0
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.